logo

For the Inventor, By the Inventor

Koenigstein, Germany

Werner Aretz

This inventor holds 21 USPTO granted patents, plus 1 CIPO patent, primarily in Biotechnology Processes. Top assignees: Hoechst Aktiengesellschaft, Aventis Pharma Deutschland, Gmbh. Active years: 1987-2003.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Werner Aretz. Retrieved from https://idiyas.com/inventor/werner-aretz

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 21

% Patents Active = 100.0


Average Co-Inventor Count = 3.3

ph-index = 7

Forward Citations = 87(Granted Patents)


Location History:

  • Kelkheim, DE (1987 - 1988)
  • Konigstein/Taunus, DE (1991 - 1998)
  • Kunigstein, DE (1998)
  • Konigstein, DE (1995 - 1999)
  • Königstein, DE (2003)

Company Filing History:

goldMedal20 out of 6,705 
 
Hoechst Aktiengesellschaft
 patents
silverMedal1 out of 330 
 
Aventis Pharma Deutschland, Gmbh
 patents

Years Active: 1987-2003

Loading Chart...
Loading Chart...
Areas of Expertise:
Lipopeptide Antibiotics
Yeast Promoter System
Glutarylacylase
Fermentation Processes
Transaminases
Chelating Agents
Bacillus Strain
Enzymes
Cytostatics
Antibiotic Production
Moenomycins
D-Aminoacid Transaminase
21 patents (USPTO):Explore Patents
1. 6624143 - Calcium salts of lipopeptide antibiotics, method for producing same and their use (2003-09-23),
2. 5866371 - Process for using the yeast ADH II promoter system for the production of (1999-02-02),
3. 5830743 - Process for the preparation of glutarylacylase in large quantities (1998-11-03),
4. 5766881 - Induction-free process for the recombinant preparation of glutarylamidase (1998-06-16),
5. 5714348 - Oxygen-dependent fermentation of microorganisms (1998-02-03),
6. 5710272 - 7-methoxymethly-3-methyl-1-(5-oxohexyl)xanthine (1998-01-20),
7. 5587319 - Process for the preparation of L-phosphinothricin using transaminases of (1996-12-24),
8. 5527697 - 7-amino-3-methoxymethyl-3-cephem-4-carboxylic ester hydrolase, process (1996-06-18),
9. 5519123 - Chelating agents, their preparation from the antibiotics salmycin A,B,C, (1996-05-21),
10. 5506140 - Bacillus strain for breaking down moenomycins (1996-04-09),
11. 5475094 - Salmycins, a process for their preparation and their use as a (1995-12-12),
12. 5472873 - Rhodotorula rubra useful in a process for the preparation of (1995-12-05),
13. 5316929 - Process for the preparation of MA (1994-05-31),
14. 5315038 - Microorganism for breaking down moenomycins, a process for the (1994-05-24),
15. 5310666 - Process for the enantioselective preparation of (1994-05-10),

Title: The Innovative Journey of Werner Aretz: A Pioneer in Biotechnology

Introduction: Werner Aretz, located in Königstein/Taunus, Germany, is a prominent inventor in the field of biotechnology, with an impressive portfolio of 21 patents. His contributions have significantly advanced the understanding and utilization of lipopeptide antibiotics and heterologous protein production.

Latest Patents: Among his most recent innovative patents is the development of calcium salts of lipopeptide antibiotics, along with a method for producing these compounds and detailing their uses. Another notable patent involves a novel process that employs the yeast ADH II promoter system for producing heterologous proteins in high yields. Specifically, this invention focuses on the preparation of valuable substances such as hirudins, miniproinsulins, leptins, and their respective derivatives.

Career Highlights: Werner Aretz has worked with prestigious companies, including Hoechst Aktiengesellschaft and Aventis Pharma Deutschland GmbH. His tenure at these organizations has enabled him to marry research with practical applications, leading to significant advancements in pharmaceutical science.

Collaborations: Throughout his career, Aretz has collaborated with esteemed colleagues, such as Klaus Sauber and Dirk Bottger. These partnerships have been crucial in fostering innovation and driving forward the boundaries of biotechnology.

Conclusion: Werner Aretz's contributions to the field of biotechnology through his patents and collaborative efforts exemplify the spirit of innovation. His work not only enhances our understanding of crucial biological processes but also paves the way for future developments in medicine and therapeutics.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…